David Hallett insider trades
Open-market stock purchases and sales by David Hallett, Chief Scientific Officer at Recursion Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 6, 2026.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Aug 17, 2026 | RXRX Recursion Pharmaceuticals, Inc | Sold (not open market) | $84.2K |
| May 15, 2026 | RXRX Recursion Pharmaceuticals, Inc | Sold (not open market) | $81K |
| Feb 17, 2026 | RXRX Recursion Pharmaceuticals, Inc | Sold (not open market) | $41.6K |
| Feb 6, 2026 | RXRX Recursion Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 6, 2026 | RXRX Recursion Pharmaceuticals, Inc | Bought (not open market) | — |
| Feb 6, 2026 | RXRX Recursion Pharmaceuticals, Inc | Sold (not open market) | $45.4K |
Companies traded
- RXRX Recursion Pharmaceuticals, Inc: other filings, last Aug 17, 2026